PMC:3320587 / 778-930 JSONTXT

{"project":"pmc-enju-pas","denotations":[{"id":"T316","span":{"begin":143,"end":146},"obj":"IN"},{"id":"T315","span":{"begin":134,"end":142},"obj":"VB"},{"id":"T314","span":{"begin":131,"end":133},"obj":"VB"},{"id":"T313","span":{"begin":124,"end":130},"obj":"NN"},{"id":"T312","span":{"begin":114,"end":123},"obj":"JJ"},{"id":"T311","span":{"begin":112,"end":113},"obj":"NN"},{"id":"T310","span":{"begin":104,"end":111},"obj":"NN"},{"id":"T309","span":{"begin":100,"end":103},"obj":"CC"},{"id":"T308","span":{"begin":98,"end":99},"obj":"NN"},{"id":"T307","span":{"begin":90,"end":97},"obj":"NN"},{"id":"T306","span":{"begin":84,"end":89},"obj":"NN"},{"id":"T305","span":{"begin":74,"end":83},"obj":"JJ"},{"id":"T304","span":{"begin":71,"end":73},"obj":"IN"},{"id":"T303","span":{"begin":62,"end":70},"obj":"NN"},{"id":"T302","span":{"begin":56,"end":61},"obj":"JJ"},{"id":"T301","span":{"begin":52,"end":55},"obj":"DT"},{"id":"T300","span":{"begin":49,"end":51},"obj":"IN"},{"id":"T299","span":{"begin":44,"end":48},"obj":"NN"},{"id":"T298","span":{"begin":36,"end":43},"obj":"NN"},{"id":"T297","span":{"begin":30,"end":35},"obj":"NN"},{"id":"T296","span":{"begin":23,"end":29},"obj":"JJ"},{"id":"T295","span":{"begin":20,"end":22},"obj":"DT"},{"id":"T294","span":{"begin":15,"end":19},"obj":"IN"},{"id":"T293","span":{"begin":11,"end":14},"obj":"CC"},{"id":"T292","span":{"begin":9,"end":10},"obj":"-COMMA-"},{"id":"T291","span":{"begin":3,"end":9},"obj":"NN"},{"id":"T290","span":{"begin":1,"end":2},"obj":"-RRB-"}],"relations":[{"id":"R122","pred":"arg1Of","subj":"T293","obj":"T292"},{"id":"R123","pred":"arg2Of","subj":"T294","obj":"T293"},{"id":"R124","pred":"arg1Of","subj":"T299","obj":"T295"},{"id":"R125","pred":"arg1Of","subj":"T299","obj":"T296"},{"id":"R126","pred":"arg1Of","subj":"T299","obj":"T297"},{"id":"R127","pred":"arg1Of","subj":"T299","obj":"T298"},{"id":"R128","pred":"arg1Of","subj":"T299","obj":"T300"},{"id":"R129","pred":"arg1Of","subj":"T299","obj":"T314"},{"id":"R130","pred":"arg2Of","subj":"T299","obj":"T315"},{"id":"R131","pred":"arg2Of","subj":"T303","obj":"T300"},{"id":"R132","pred":"arg1Of","subj":"T303","obj":"T301"},{"id":"R133","pred":"arg1Of","subj":"T303","obj":"T302"},{"id":"R134","pred":"arg1Of","subj":"T303","obj":"T304"},{"id":"R135","pred":"arg1Of","subj":"T308","obj":"T309"},{"id":"R136","pred":"arg2Of","subj":"T310","obj":"T309"},{"id":"R137","pred":"arg2Of","subj":"T313","obj":"T304"},{"id":"R138","pred":"arg1Of","subj":"T313","obj":"T305"},{"id":"R139","pred":"arg1Of","subj":"T313","obj":"T306"},{"id":"R140","pred":"arg1Of","subj":"T313","obj":"T307"},{"id":"R141","pred":"arg1Of","subj":"T313","obj":"T308"},{"id":"R142","pred":"arg1Of","subj":"T313","obj":"T310"},{"id":"R143","pred":"arg1Of","subj":"T313","obj":"T311"},{"id":"R144","pred":"arg1Of","subj":"T313","obj":"T312"},{"id":"R145","pred":"arg2Of","subj":"T315","obj":"T294"},{"id":"R146","pred":"arg2Of","subj":"T315","obj":"T314"},{"id":"R147","pred":"arg1Of","subj":"T315","obj":"T316"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T414","span":{"begin":30,"end":35},"obj":"http://www.uniprot.org/uniprot/O94916"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"GO-MF","denotations":[{"id":"T117","span":{"begin":3,"end":9},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T118","span":{"begin":36,"end":43},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T456","span":{"begin":134,"end":142},"obj":"Positive_regulation"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T823","span":{"begin":20,"end":48},"obj":"Binding"},{"id":"T782","span":{"begin":52,"end":97},"obj":"Entity"},{"id":"T788","span":{"begin":30,"end":35},"obj":"Protein"},{"id":"T790","span":{"begin":20,"end":48},"obj":"Entity"}],"relations":[{"id":"R600","pred":"themeOf","subj":"T790","obj":"T823"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T647","span":{"begin":98,"end":99},"obj":"NNP"},{"id":"T646","span":{"begin":90,"end":97},"obj":"NN"},{"id":"T645","span":{"begin":84,"end":89},"obj":"NN"},{"id":"T644","span":{"begin":74,"end":83},"obj":"JJ"},{"id":"T643","span":{"begin":71,"end":73},"obj":"IN"},{"id":"T642","span":{"begin":62,"end":70},"obj":"NN"},{"id":"T641","span":{"begin":56,"end":61},"obj":"JJ"},{"id":"T640","span":{"begin":52,"end":55},"obj":"DT"},{"id":"T639","span":{"begin":49,"end":51},"obj":"IN"},{"id":"T638","span":{"begin":44,"end":48},"obj":"NN"},{"id":"T637","span":{"begin":36,"end":43},"obj":"JJ"},{"id":"T636","span":{"begin":30,"end":35},"obj":"NNP"},{"id":"T635","span":{"begin":23,"end":29},"obj":"JJ"},{"id":"T634","span":{"begin":20,"end":22},"obj":"DT"},{"id":"T633","span":{"begin":15,"end":19},"obj":"IN"},{"id":"T632","span":{"begin":11,"end":14},"obj":"CC"},{"id":"T631","span":{"begin":9,"end":10},"obj":","},{"id":"T630","span":{"begin":3,"end":9},"obj":"NN"},{"id":"T629","span":{"begin":1,"end":2},"obj":"-RRB-"},{"id":"T648","span":{"begin":100,"end":103},"obj":"CC"},{"id":"T649","span":{"begin":104,"end":111},"obj":"JJ"},{"id":"T650","span":{"begin":112,"end":113},"obj":"NNP"},{"id":"T651","span":{"begin":114,"end":123},"obj":"JJ"},{"id":"T652","span":{"begin":124,"end":130},"obj":"NNS"},{"id":"T653","span":{"begin":131,"end":133},"obj":"VBZ"},{"id":"T654","span":{"begin":134,"end":142},"obj":"VBN"},{"id":"T655","span":{"begin":143,"end":146},"obj":"IN"}],"relations":[{"id":"R365","pred":"punct","subj":"T631","obj":"T630"},{"id":"R367","pred":"mark","subj":"T633","obj":"T654"},{"id":"R368","pred":"det","subj":"T634","obj":"T638"},{"id":"R369","pred":"amod","subj":"T635","obj":"T638"},{"id":"R370","pred":"nmod","subj":"T636","obj":"T638"},{"id":"R371","pred":"amod","subj":"T637","obj":"T638"},{"id":"R372","pred":"nsubjpass","subj":"T638","obj":"T654"},{"id":"R373","pred":"prep","subj":"T639","obj":"T638"},{"id":"R374","pred":"det","subj":"T640","obj":"T642"},{"id":"R375","pred":"amod","subj":"T641","obj":"T642"},{"id":"R376","pred":"pobj","subj":"T642","obj":"T639"},{"id":"R377","pred":"prep","subj":"T643","obj":"T642"},{"id":"R378","pred":"nmod","subj":"T644","obj":"T647"},{"id":"R379","pred":"nmod","subj":"T645","obj":"T647"},{"id":"R380","pred":"compound","subj":"T646","obj":"T647"},{"id":"R381","pred":"nmod","subj":"T647","obj":"T652"},{"id":"R546","pred":"cc","subj":"T648","obj":"T647"},{"id":"R547","pred":"amod","subj":"T649","obj":"T652"},{"id":"R548","pred":"nmod","subj":"T650","obj":"T652"},{"id":"R549","pred":"amod","subj":"T651","obj":"T652"},{"id":"R550","pred":"pobj","subj":"T652","obj":"T643"},{"id":"R551","pred":"auxpass","subj":"T653","obj":"T654"},{"id":"R553","pred":"prep","subj":"T655","obj":"T654"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T132","span":{"begin":30,"end":48},"obj":"Protein"}],"text":"R) ligand, and that an intact NFAT5 binding site in the viral promoter of R5-tropic HIV-1 subtype B and subtype C molecular clones is required for effic"}